These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 28577975
1. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. Lu SX, Zhang CZ, Luo RZ, Wang CH, Liu LL, Fu J, Zhang L, Wang H, Xie D, Yun JP. Cancer Lett; 2017 Aug 28; 402():71-80. PubMed ID: 28577975 [Abstract] [Full Text] [Related]
2. MicroRNA-433 inhibits cell proliferation in hepatocellular carcinoma by targeting p21 activated kinase (PAK4). Xue J, Chen LZ, Li ZZ, Hu YY, Yan SP, Liu LY. Mol Cell Biochem; 2015 Jan 28; 399(1-2):77-86. PubMed ID: 25410752 [Abstract] [Full Text] [Related]
3. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Bao L, Yan Y, Xu C, Ji W, Shen S, Xu G, Zeng Y, Sun B, Qian H, Chen L, Wu M, Su C, Chen J. Cancer Lett; 2013 Sep 01; 337(2):226-36. PubMed ID: 23684551 [Abstract] [Full Text] [Related]
4. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis. Mak GW, Chan MM, Leong VY, Lee JM, Yau TO, Ng IO, Ching YP. Cancer Res; 2011 Apr 15; 71(8):2949-58. PubMed ID: 21385901 [Abstract] [Full Text] [Related]
5. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway. Li SQ, Wang ZH, Mi XG, Liu L, Tan Y. IUBMB Life; 2015 Oct 15; 67(10):768-77. PubMed ID: 26399456 [Abstract] [Full Text] [Related]
6. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression. Xiao CZ, Wei W, Guo ZX, Zhang MY, Zhang YF, Wang JH, Shi M, Wang HY, Guo RP. J Cancer Res Clin Oncol; 2017 Feb 15; 143(2):263-273. PubMed ID: 27704267 [Abstract] [Full Text] [Related]
7. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5. Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H. Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554 [Abstract] [Full Text] [Related]
8. MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis. Sun W, Zhang Z, Wang J, Shang R, Zhou L, Wang X, Duan J, Ruan B, Gao Y, Dai B, Qu S, Liu W, Ding R, Wang L, Wang D, Dou K. Oncotarget; 2016 Mar 08; 7(10):11595-608. PubMed ID: 26871477 [Abstract] [Full Text] [Related]
9. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways. Fang F, Song T, Zhang T, Cui Y, Zhang G, Xiong Q. Oncotarget; 2017 May 09; 8(19):31745-31757. PubMed ID: 28423650 [Abstract] [Full Text] [Related]
10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092 [Abstract] [Full Text] [Related]
11. Vaccinia-related kinase 1 promotes hepatocellular carcinoma by controlling the levels of cell cycle regulators associated with G1/S transition. Lee N, Kwon JH, Kim YB, Kim SH, Park SJ, Xu W, Jung HY, Kim KT, Wang HJ, Choi KY. Oncotarget; 2015 Oct 06; 6(30):30130-48. PubMed ID: 26375549 [Abstract] [Full Text] [Related]
12. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Wang WM, Xu Y, Wang YH, Sun HX, Sun YF, He YF, Zhu QF, Hu B, Zhang X, Xia JL, Qiu SJ, Zhou J, Yang XR, Fan J. Oncotarget; 2017 Jul 18; 8(29):47121-47135. PubMed ID: 28454092 [Abstract] [Full Text] [Related]
13. Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway. Qi J, Zhao P, Li F, Guo Y, Cui H, Liu A, Mao H, Zhao Y, Zhang X. Int J Clin Exp Pathol; 2015 Jul 18; 8(5):4963-71. PubMed ID: 26191189 [Abstract] [Full Text] [Related]
14. Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway. Chan KK, Leung CO, Wong CC, Ho DW, Chok KS, Lai CL, Ng IO, Lo RC. Cancer Lett; 2017 Sep 10; 403():330-338. PubMed ID: 28688970 [Abstract] [Full Text] [Related]
15. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma. Zhang B, Zhang Y, Zou X, Chan AW, Zhang R, Lee TK, Liu H, Lau EY, Ho NP, Lai PB, Cheung YS, To KF, Wong HK, Choy KW, Keng VW, Chow LM, Chan KK, Cheng AS, Ko BC. J Pathol; 2017 Dec 10; 243(4):418-430. PubMed ID: 28862757 [Abstract] [Full Text] [Related]
16. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429. Sui CJ, Zhou YM, Shen WF, Dai BH, Lu JJ, Zhang MF, Yang JM. J Mol Med (Berl); 2016 Nov 10; 94(11):1281-1296. PubMed ID: 27380494 [Abstract] [Full Text] [Related]
17. PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinoma. Leung CO, Wong CC, Fan DN, Kai AK, Tung EK, Xu IM, Ng IO, Lo RC. Oncotarget; 2015 May 10; 6(13):10880-92. PubMed ID: 25834102 [Abstract] [Full Text] [Related]
18. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Buurman R, Gürlevik E, Schäffer V, Eilers M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F, Skawran B. Gastroenterology; 2012 Sep 10; 143(3):811-820.e15. PubMed ID: 22641068 [Abstract] [Full Text] [Related]
19. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G, Chao YL, Tang B, Li BS, Xiao YF, Xie R, Wang SM, Wu YY, Dong H, Liu XD, Yang SM. Oncotarget; 2015 Nov 10; 6(35):37808-23. PubMed ID: 26498692 [Abstract] [Full Text] [Related]
20. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4. Zhao Y, Li F, Zhang X, Liu A, Qi J, Cui H, Zhao P. Int J Clin Exp Pathol; 2015 Nov 10; 8(10):12446-54. PubMed ID: 26722431 [Abstract] [Full Text] [Related] Page: [Next] [New Search]